Lantheus Email Format

Pharmaceutical Manufacturing
501-1,000 employees
Bedford, MA, USA

Lantheus is a radiopharmaceutical-focused company delivering diagnostic and therapeutic solutions across oncology, neurology, and cardiology to clinicians worldwide.

Find contacts at Lantheus

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@lantheus.com

Company Overview

Industry
Pharmaceutical Manufacturing
Founded
1956
Headquarters
Bedford, MA, USA
Revenue
$1B-$2.5B
FUNDING Stage
Public
Key Executives
Mary Anne Heino (Executive Chairperson and Interim CEO), Robert J. Marshall, Jr. (Chief Financial Officer and Treasurer), Lee Anne Howe (Chief Information Officer)

Tech Stack

Databricks

Analytics

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Lantheus?

Lantheus uses the first.last format, so Jane Smith would be jane.smith@lantheus.com.

What is PYLARIFY, and how does it fit into Lantheus's oncology portfolio?

PYLARIFY is Lantheus's market-leading PSMA PET imaging agent used to detect prostate cancer. It is the flagship product in the Lantheus Radiopharmaceutical Oncology segment and generated $240.9 million in revenue in Q1 2026 alone.

How many employees does Lantheus have?

Lantheus has approximately 1,278 employees and is headquartered in Bedford, MA. Tools like Clay can help you identify and reach the right Lantheus contacts within that workforce for targeted outreach.

Which therapeutic and diagnostic areas does Lantheus focus on?

Lantheus focuses on oncology including prostate cancer and neuroendocrine tumors, neurology, and cardiology, developing radiodiagnostic and radiotherapeutic products such as PYLARIFY, DEFINITY, and Neuraceq across those disease areas.

Who leads Lantheus as CEO in 2026?

Mary Anne Heino serves as Executive Chairperson and Interim CEO of Lantheus in 2026, with Robert J. Marshall, Jr. as Chief Financial Officer and Treasurer supporting the executive leadership team.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles